Skip to main content

Table 1 Patients’ characteristics; Details on patients included in immunohistochemistry (A) and EIA study (B) are shown

From: Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients

Stage

Patients (n)

I

34

II

10

III

100

IV

3

n.a.

5

Grade

 

G1

37

G2

50

G3

53

n.a.

12

deaths

102

cystic lesions

21

inflammatory diseases

18

benign tumors

34

malignant tumors

38

total

111

  1. n.a. = data on grade/FIGO stage were not available.
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us